A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Dario Ferrero, Ermanno Venturino et al.|Annals of Hematology|2010Cited by 60
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Mario Boccadoro, Elena Crisà et al.|Annals of Hematology|2014Cited by 31
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Dario Ferrero et al.|Mechanisms of Ageing and Development|2012Cited by 9
Long‐term follow‐up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13‐<i>cis</i>‐retinoic acid and dihydroxylated vitamin <scp>D</scp>3: independent positive impact of erythroid response on survivalElena Crisà, Dario Ferrero, Cristina Foli et al.|British Journal of Haematology|2012Cited by 9
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patientsLucia Brunello, Benedetto Bruno, Roberto Passera et al.|Annals of Hematology|2018Cited by 4